Treatment of zoster with idoxuridine in dimethyl sulphoxide. Results of two double-blind controlled trials

Br Med J. 1970 Dec 26;4(5738):776-80. doi: 10.1136/bmj.4.5738.776.

Abstract

The antiviral effect of 5% idoxuridine in dimethyl sulphoxide intermittently applied and of 40% idoxuridine in dimethyl sulphoxide continuously applied for four days to the lesions in patients with zoster of recent onset was studied in two double-blind controlled trials. Most, but not all, of the patients receiving intermittent active treatment had pain for a short period only. The effect of continuous treatment was striking: pain had disappeared within nine days in all the patients and healing was accelerated. The results were statistically significant.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Aged
  • Blood Cell Count
  • Child
  • Clinical Trials as Topic
  • Dimethyl Sulfoxide / therapeutic use*
  • Dosage Forms
  • Female
  • Herpes Zoster / drug therapy*
  • Humans
  • Idoxuridine / administration & dosage
  • Idoxuridine / therapeutic use*
  • Male
  • Middle Aged

Substances

  • Dosage Forms
  • Idoxuridine
  • Dimethyl Sulfoxide